Nuvectis intends to use the net proceeds from the offering to continue to advance the development programs of NXP800 and NXP900 or any future product candidate, hiring of additional personnel, capital ...
Capital Markets initiated coverage on Portman Ridge Finance Corp. (NASDAQ:PTMN), a $156.71 million market cap company, with a Buy rating and a price target of $19.00. The firm's analyst pointed to the ...
Meme stock SoundHound AI (SOUN) is making its in-car voice assistants a little more personal, with a flashy new customization ...
KBC Group NV raised its position in shares of Lucid Group, Inc. (NASDAQ:LCID – Free Report) by 113.0% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 58,391 shares of ...
SANTA CLARA, Calif. - SoundHound AI , Inc. (NASDAQ:SOUN), a rapidly growing voice artificial intelligence company with 76% year-over-year revenue growth, has recently launched Brand Personalities for ...
Nuvectis intends to use the net proceeds from the offering to continue to advance the development programs of NXP800 and NXP900 or any future product candidate, hiring of additional personnel, capital ...
To be fair, part of the reason why TH ranks among the cheap stocks under $10 is that prior to Trump 2.0, the prospects for continued fossil-fuel development looked dim. Notably, in the third calendar ...
It's 2025, and the generative artificial intelligence (AI) hype cycle is getting a little long in the tooth. Over the next ...
JMP Securities maintained a Market Perform rating on Capital Southwest Corporation (NASDAQ:CSWC), reflecting a consistent performance and solid fundamentals. The firm's analyst highlighted CSWC's ...
Lucid Group (NASDAQ: LCID) is entering one of the most exciting years in its history. Following the recent launch of its ...
Nancy Denyes, General Counsel at aTyr Pharma Inc. (NASDAQ:ATYR), recently reported a sale of company shares. According to a Form 4 filing with the Securities and Exchange Commission, Denyes sold 899 ...
FORT LEE, NJ - Nuvectis Pharma , Inc. (NASDAQ:NVCT), a biopharmaceutical company specializing in precision oncology medicines with a current market capitalization of $131 million, announced today its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results